Inositol and Omega-3 Fatty Acids in Pediatric Mania
This study is currently recruiting participants.
Verified June 2017 by Janet Wozniak, MD, Massachusetts General Hospital
Massachusetts General Hospital
Information provided by (Responsible Party):
Janet Wozniak, MD, Massachusetts General Hospital
First received: July 15, 2011
Last updated: June 28, 2017
Last verified: June 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||January 2019|
|Estimated Primary Completion Date:||January 2019 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Wozniak J, Faraone SV, Chan J, Tarko L, Hernandez M, Davis J, Woodworth KY, Biederman J. A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study. J Clin Psychiatry. 2015 Nov;76(11):1548-55. doi: 10.4088/JCP.14m09267. Erratum in: J Clin Psychiatry. 2016 Sep;77(9):e1153.